Literature DB >> 16270383

Low prevalence of germline hMSH6 mutations in colorectal cancer families from Spain.

Ana Sánchez de Abajo1, Miguel de la Hoya, Alicia Tosar, Javier Godino, Juan-Manuel Fernández, Jose-Lopez Asenjo, Beatriz-Perez Villamil, Pedro-Perez Segura, Eduardo Diaz-Rubio, Trinidad Caldes.   

Abstract

AIM: To investigate the prevalence and penetrance of hMSH6 mutations in Spanish HNPCC families that was negative for mutation in hMLH1 or hMSH2.
METHODS: We used PCR-based DGGE assay and direct sequencing to screen for hMSH6 gene in 91 HNPCC families.
RESULTS: we have identified 10 families with germ-line mutations in the DNA sequence. These mutations included two intronic variation, three missense mutation, one nonsense mutation, and four silent mutations. Among the 10 germ-line mutations identified in the Spanish cohort, 8 were novel, perhaps, suggesting different mutational spectra in the Spanish population. Detailed pedigrees were constructed for the three families with a possible pathogenic hMSH6 mutation. The two silent mutations H388H and L758L, detected in a person affected of colorectal cancer at age 29, produce loss of the wild-type allele in the tumor sample. Immunohistochemical analysis showed that expression of MSH6 protein was lost only in the tumors from the carriers of V878A and Q263X mutations.
CONCLUSION: Altogether, our results indicate that disease-causing germ-line mutations of hMSH6 are very less frequent in Spanish HNPCC families.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16270383      PMCID: PMC4479674          DOI: 10.3748/wjg.v11.i37.5770

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  Denaturing gradient gel electrophoresis-based analysis of loss of heterozygosity distinguishes nonobvious, deleterious BRCA1 variants from nonpathogenic polymorphisms.

Authors:  M de La Hoya; E Díaz-Rubio; T Caldés
Journal:  Clin Chem       Date:  1999-11       Impact factor: 8.327

2.  Eight novel germline MLH1 and MSH2 mutations in hereditary non-polyposis colorectal cancer families from Spain.

Authors:  J Godino; M de La Hoya; E Diaz-Rubio; M Benito; T Caldés
Journal:  Hum Mutat       Date:  2001-12       Impact factor: 4.878

Review 3.  Do MSH6 mutations contribute to double primary cancers of the colorectum and endometrium?

Authors:  G S Charames; A L Millar; T Pal; S Narod; B Bapat
Journal:  Hum Genet       Date:  2000-12       Impact factor: 4.132

4.  Novel dominant mutations in Saccharomyces cerevisiae MSH6.

Authors:  R Das Gupta; R D Kolodner
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

5.  The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas.

Authors:  J M Cunningham; C Y Kim; E R Christensen; D J Tester; Y Parc; L J Burgart; K C Halling; S K McDonnell; D J Schaid; C Walsh Vockley; V Kubly; H Nelson; V V Michels; S N Thibodeau
Journal:  Am J Hum Genet       Date:  2001-08-24       Impact factor: 11.025

6.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

Authors:  H F Vasen; P Watson; J P Mecklin; H T Lynch
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

7.  BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines.

Authors:  J M Hoang; P H Cottu; B Thuille; R J Salmon; G Thomas; R Hamelin
Journal:  Cancer Res       Date:  1997-01-15       Impact factor: 12.701

Review 8.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

9.  Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history.

Authors:  Barbara M Buttin; Matthew A Powell; David G Mutch; Sheri A Babb; Phyllis C Huettner; Tina Bocker Edmonston; Thomas J Herzog; Janet S Rader; Randall K Gibb; Alison J Whelan; Paul J Goodfellow
Journal:  Am J Hum Genet       Date:  2004-04-19       Impact factor: 11.025

10.  MSH6 germline mutations are rare in colorectal cancer families.

Authors:  Paolo Peterlongo; Khedoudja Nafa; Gabriel S Lerman; Emily Glogowski; Jinru Shia; Tian Z Ye; Arnold J Markowitz; José G Guillem; Prema Kolachana; Jeffrey A Boyd; Kenneth Offit; Nathan A Ellis
Journal:  Int J Cancer       Date:  2003-11-20       Impact factor: 7.396

View more
  7 in total

1.  Reassessing the TARBP2 mutation rate in hereditary nonpolyposis colorectal cancer.

Authors:  Pilar Garre; Pedro Pérez-Segura; Eduardo Díaz-Rubio; Trinidad Caldés; Miguel de la Hoya
Journal:  Nat Genet       Date:  2010-10       Impact factor: 38.330

2.  Cancer risk and overall survival in mismatch repair proficient hereditary non-polyposis colorectal cancer, Lynch syndrome and sporadic colorectal cancer.

Authors:  Pilar Garre; Lorena Martín; Inmaculada Bando; Alicia Tosar; Patricia Llovet; Julián Sanz; Atocha Romero; Miguel de la Hoya; Eduardo Díaz-Rubio; Trinidad Caldés
Journal:  Fam Cancer       Date:  2014-03       Impact factor: 2.375

3.  Association of MUTYH and MSH6 germline mutations in colorectal cancer patients.

Authors:  María Dolores Giráldez; Francesc Balaguer; Trinidad Caldés; Ana Sanchez-de-Abajo; Nuria Gómez-Fernández; Clara Ruiz-Ponte; Jenifer Muñoz; Pilar Garre; Victoria Gonzalo; Leticia Moreira; Teresa Ocaña; Joan Clofent; Angel Carracedo; Montserrat Andreu; Rodrigo Jover; Xavier Llor; Antoni Castells; Sergi Castellví-Bel
Journal:  Fam Cancer       Date:  2009-08-15       Impact factor: 2.375

4.  Co-occurrence of nonsense mutations in MSH6 and MSH2 in Lynch syndrome families evidencing that not all truncating mutations are equal.

Authors:  Carla Pinto; Manuela Pinheiro; Ana Peixoto; Catarina Santos; Isabel Veiga; Patrícia Rocha; Pedro Pinto; Paula Lopes; Manuela Baptista; Rui Henrique; Manuel R Teixeira
Journal:  J Hum Genet       Date:  2015-10-08       Impact factor: 3.172

5.  Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome.

Authors:  Gasper Berginc; Matej Bracko; Metka Ravnik-Glavac; Damjan Glavac
Journal:  Fam Cancer       Date:  2009-06-13       Impact factor: 2.375

6.  Frequency and variability of genomic rearrangements on MSH2 in Spanish Lynch Syndrome families.

Authors:  Atocha Romero; Pilar Garre; Olivia Valentin; Julian Sanz; Pedro Pérez-Segura; Patricia Llovet; Eduardo Díaz-Rubio; Miguel de la Hoya; Trinidad Caldés
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

7.  Functional examination of MLH1, MSH2, and MSH6 intronic mutations identified in Danish colorectal cancer patients.

Authors:  Sanne M Petersen; Mette Dandanell; Lene J Rasmussen; Anne-Marie Gerdes; Lotte N Krogh; Inge Bernstein; Henrik Okkels; Friedrik Wikman; Finn C Nielsen; Thomas V O Hansen
Journal:  BMC Med Genet       Date:  2013-10-03       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.